Altimmune (ALT) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Altimmune (ALT) over the last 17 years, with Q3 2025 value amounting to -$622.1 million.
- Altimmune's Retained Earnings fell 1559.15% to -$622.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$622.1 million, marking a year-over-year decrease of 1559.15%. This contributed to the annual value of -$561.4 million for FY2024, which is 2038.44% down from last year.
- Per Altimmune's latest filing, its Retained Earnings stood at -$622.1 million for Q3 2025, which was down 1559.15% from -$603.1 million recorded in Q2 2025.
- In the past 5 years, Altimmune's Retained Earnings ranged from a high of -$210.9 million in Q1 2021 and a low of -$622.1 million during Q3 2025
- Moreover, its 5-year median value for Retained Earnings was -$414.0 million (2023), whereas its average is -$421.8 million.
- As far as peak fluctuations go, Altimmune's Retained Earnings crashed by 5726.32% in 2021, and later tumbled by 1559.15% in 2025.
- Altimmune's Retained Earnings (Quarter) stood at -$293.2 million in 2021, then decreased by 28.9% to -$377.9 million in 2022, then decreased by 23.41% to -$466.3 million in 2023, then fell by 20.38% to -$561.4 million in 2024, then fell by 10.82% to -$622.1 million in 2025.
- Its last three reported values are -$622.1 million in Q3 2025, -$603.1 million for Q2 2025, and -$581.0 million during Q1 2025.